Intech Investment Management LLC Raises Stock Position in Prestige Consumer Healthcare Inc. $PBH

Key Points

• Intech Investment Management LLC increased its holdings in Prestige Consumer Healthcare by 18.9%, owning 27,307 shares valued at $2.35 million as of the latest SEC filing.
• Despite reporting earnings of $0.95 per share for the most recent quarter, Prestige missed analysts' expectations by $0.06, with revenue declining 6.6% year-over-year.
• Three analysts rated Prestige with a Buy, three with a Hold, and one with a Sell, indicating a consensus rating of "Hold" with an average target price of $93.33.

Intech Investment Management LLC lifted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 18.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 27,307 shares of the company's stock after purchasing an additional 4,343 shares during the period. Intech Investment Management LLC owned about 0.06% of Prestige Consumer Healthcare worth $2,348,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Prestige Consumer Healthcare by 45.3% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,580,819 shares of the company's stock valued at $135,903,000 after buying an additional 493,199 shares during the last quarter. Invesco Ltd. raised its holdings in Prestige Consumer Healthcare by 24.7% during the first quarter. Invesco Ltd. now owns 1,321,800 shares of the company's stock worth $113,635,000 after purchasing an additional 261,537 shares in the last quarter. Congress Asset Management Co. increased its holdings in shares of Prestige Consumer Healthcare by 9.1% in the 1st quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after acquiring an additional 82,838 shares during the period. Westwood Holdings Group Inc. increased its stake in Prestige Consumer Healthcare by 7.1% in the 1st quarter. Westwood Holdings Group Inc. now owns 861,282 shares of the company's stock valued at $74,044,000 after buying an additional 56,802 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Prestige Consumer Healthcare by 4.8% in the 1st quarter. Northern Trust Corp now owns 852,274 shares of the company's stock worth $73,270,000 after buying an additional 39,198 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on PBH. Canaccord Genuity Group dropped their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Wall Street Zen cut Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Zacks Research lowered Prestige Consumer Healthcare from a "hold" rating to a "strong sell" rating in a report on Thursday, September 4th. Three research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Prestige Consumer Healthcare has a consensus rating of "Hold" and an average price target of $93.33.

Prestige Consumer Healthcare Stock Down 1.5%

NYSE PBH traded down $0.99 during mid-day trading on Friday, reaching $63.11. The stock had a trading volume of 1,033,476 shares, compared to its average volume of 567,570. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. Prestige Consumer Healthcare Inc. has a 1 year low of $61.93 and a 1 year high of $90.04. The stock has a market cap of $3.11 billion, a PE ratio of 14.81, a price-to-earnings-growth ratio of 2.03 and a beta of 0.46. The company has a fifty day moving average price of $69.07 and a 200 day moving average price of $78.49.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The company had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. During the same period last year, the firm posted $0.90 EPS. The company's revenue for the quarter was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. On average, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.